País: Canadá
Língua: inglês
Origem: Health Canada
ESTRADIOL (ESTRADIOL HEMIHYDRATE)
SANDOZ CANADA INCORPORATED
G03CA03
ESTRADIOL
75MCG
PATCH
ESTRADIOL (ESTRADIOL HEMIHYDRATE) 75MCG
TRANSDERMAL
8
Prescription
ESTROGENS
Active ingredient group (AIG) number: 0106457036; AHFS:
APPROVED
2006-01-11
PRODUCT MONOGRAPH SANDOZ ESTRADIOL DERM 50, 75 AND 100 ESTRADIOL HEMIHYDRATE (ESTRADIOL-17Β) TRANSDERMAL THERAPEUTIC SYSTEM 4, 6 AND 8 MG ESTRADIOL PATCHES CORRESPONDING TO 50 MCG/DAY, 75 MCG/DAY AND 100 MCG/DAY DELIVERY ESTROGEN Sandoz Canada Inc. 145 Jules-Léger Date of Revision: March 19, 2009 Boucherville, QC, Canada J4B 7K8 CONTROL NUMBER: 120474 _ _ _Sandoz Estradiol Derm _ _Page 2 of 34 _ _ _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION......................................................................................... 3 SUMMARY PRODUCT INFORMATION............................................................................................................... 3 INDICATIONS AND CLINICAL USE .................................................................................................................... 3 CONTRAINDICATIONS ......................................................................................................................................... 3 WARNINGS AND PRECAUTIONS ........................................................................................................................ 4 ADVERSE REACTIONS........................................................................................................................................ 11 DRUG INTERACTIONS ........................................................................................................................................ 12 DOSAGE AND ADMINISTRATION .................................................................................................................... 14 OVERDOSAGE ...................................................................................................................................................... 16 ACTIONS AND CLINICAL PHARMACOLOGY................................................................................................. 16 STORAGE AND STABILITY ..................................................................................................................... Leia o documento completo